When engineered KPC cells (hereafter referred to as KPC1) were injected orthotopically in the pancreas, the effects of Slc4a4 depletion were even more pronounced, with a reduction in tumor growth of almost 90% (Fig. 2g). This evidence concerns the gene SLC4A4 and neoplasm.